AI assistant
AVADEL PHARMACEUTICALS PLC — Director's Dealing 2020
Dec 23, 2020
31920_dirs_2020-12-23_f1c3b4b7-f2fd-496a-b5b7-84eb1c53701d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2020-12-21
Reporting Person: Glass Geoffrey Michael (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-21 | ADSs | G | 18600 | — | Disposed | 47100 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-21 | Stock Option (Right to Buy) | $2.03 | G | 60000 | Acquired | 2029-08-07 | ADSs (60000) | Direct |
| 2020-12-21 | Stock Option (Right to Buy) | $8.48 | G | 42000 | Acquired | 2030-08-07 | ADSs (42000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ADSs | 18600 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.03 | 2029-08-07 | ADSs (60000) | 60000 | Indirect |
| Stock Option (Right to Buy) | $8.48 | 2030-08-07 | ADSs (42000) | 42000 | Indirect |
Footnotes
F1: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
F2: On December 21, 2020, the reporting person transferred 18,600 ADSs to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
F3: On December 21, 2020, the reporting person transferred 60,000 options to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
F4: Options become exercisable as to 20,000 ADSs on each of the first three anniversaries after the 08/07/2019 grant date.
F5: On December 21, 2020, the reporting person transferred 42,000 options to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
F6: Options become exercisable as to 14,000 ADSs on each of the first three anniversaries after the 08/07/2020 grant date.